EPO Ceasefire? Amgen Aranesp Price To Remain Stable Unless J&J Acts First

Amgen does not intend to continue implementing Aranesp price discounts unless J&J moves first, Amgen Exec VP-Global Commercial Operations George Morrow said during an earnings call April 22